Provider
P44-16 Addition of a Drug (Viekira XR) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Program effective Date: Sep 01, 2016
Search Results
Displaying 3181 - 3190 of 3887 results
Provider
P47-17 Change to the Requirement to Submit National Drug Codes
Program effective Date: Aug 23, 2017
Provider
P36-16 Case Management (T1016) Billing for Tuberculosis Related Services for Government Programs Subscribers
Program effective Date: Jul 27, 2016
Provider
P60-16 New Drug-Related Prior Authorization Criteria with Quanatity Limit for Topical Diclofenac Gel, Fluorourcil Cream, Imquimod Cream and Ingenol Gel
Program effective Date: Dec 13, 2016
Provider
P39-16 Expansion of Drug-Related Xenazine Prior Authorization Criteria with Quantity Limit to Minnesota Health Care Programs
Program effective Date: Aug 03, 2016
Provider
P40-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Lidocaine Transdermal
Program effective Date: Aug 03, 2016
Provider
P45R1-16 Update on New Drug, Ocrevus (ocrelizumab)
Program effective Date: Dec 05, 2016
Provider
P45-16 A New Drug, Ocrevus (ocrelizumab) Will Require Prior Authorization
Program effective Date: Dec 05, 2016
Provider
P57-16 Change in Medical Policy and Commercial Benefit Coverage of CT Colonography Colorectal Cancer Screening Test
Program effective Date: Nov 22, 2016
Provider
P37-16 Addition of a Drug (Epclusa) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Program effective Date: Aug 03, 2016